Hostname: page-component-cb9f654ff-mwwwr Total loading time: 0 Render date: 2025-08-28T09:04:57.905Z Has data issue: false hasContentIssue false
  • English
  • Français

HLA Antigens in Schizophrenia: No Difference Between Patients with and Without Evidence of Brain Atrophy

Published online by Cambridge University Press:  29 January 2018

Elias Frangos ,
Nitsa Renieri-Livieratou ,
George Athanassenas ,
Ekaterini Stavropoulou-Ghioka  and
Antony Kourkoubas
Elias Frangos
Affiliation:
3rd Department of Psychiatry, State Mental Hospital of Athens, Daphni, Greece
Nitsa Renieri-Livieratou
Affiliation:
Tissue Typing Laboratory, General Hospital of Athens, Greece
George Athanassenas
Affiliation:
3rd Department of Psychiatry, State Mental Hospital of Athens, Daphni, Greece
Ekaterini Stavropoulou-Ghioka
Affiliation:
Tissue Typing Laboratory, General Hospital of Athens, Greece
Antony Kourkoubas
Affiliation:
3rd Department of Psychiatry, State Mental Hospital of Athens, Daphni, Greece
Get access Rights & Permissions [Opens in a new window]

Summary

The HLA antigens distribution was studied in 56 chronic schizophrenic in-patients with or without brain atrophy determined by CAT examination, and compared with that of 200 controls. There was no difference in the incidence of HLA-A2 in the whole sample, and an increase in those without brain atrophy (by comparison with normal controls) failed to reach statistical significance. A decrease of Bw35 in the whole sample, more prominent in those without brain atrophy, again failed to be significant after multiplying the probability by the number of antigens studied.

Information

Type
Research Article
Information
The British Journal of Psychiatry , Volume 140 , Issue 6 , June 1982 , pp. 607 - 610
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Barron, S. A., Jacobs, L. & Kinkel, W. (1976) Changes in size of normal lateral ventricles during aging determined by computerized tomography. Neurology, 26, 1011–13.Google Scholar
Cazzullo, C. L., Smeraldi, E. & Penati, G. (1974) The leucocyte antigenic system as a possible genetic marker of schizophrenia. British Journal of Psychiatry, 125, 25–7.Google Scholar
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G. & Munoz, R. (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.Google Scholar
Frangos, E., Athanassenas, G., Gregoriadis, A. & Kapsalakis, Z. (1982) The enlargement of lateral brain ventricles in chronic schizophrenics. Enkephalos, 19 (1), in press.Google Scholar
Kyner, W. T., Bennhahum, D. A., Troup, G. M., Rada, R. T. & Kellner, R. (1978) The HLA-SD antigens and schizophrenia-A statistical analysis. In Neurochemical and Immunological Components in Schizophrenia, (eds. Bergsma, D. and Goldstein, A. L.). New York: Alan R. Liss Google Scholar
Luchins, D. J., Torrey, E. F., Weinberger, D. R., Zalcman, S., Delici, L., Johnson, A., Rogentine, N. & Wyatt, R. J. (1980) HLA antigens in schizophrenia: differences between patients with and without evidence of brain atrophy. British Journal of Psychiatry, 136, 243–8.Google Scholar
Luchins, D. J. Weinberger, D. R., Kleinman, J. E., Neckers, L., Rosenblatt, J. E., Bigelow, L. B. & Wyatt, R. J. (1980) Human leucocyte antigen A2 and psychopathology in chronic schizophrenia. American Journal of Psychiatry, 137, 499–500.Google Scholar
McGuffin, P., Farmer, A. A. E. & Rajah, S. M. (1978) Histocompatibility antigens and schizophrenia. British Journal of Psychiatry, 132, 149–51.Google Scholar
Mendlewicz, J., Verbanck, P., Linkowski, P., Govaerts, A. (1978) HLA antigens in affective disorders. Paper presented at the 11th CINP Congress, Vienna.Google Scholar
Renieri-Livieratou, N., Stavropoulou-Gioka, E. & Kapellou, P. (1979) The distribution of HLA antigens in the Greek population. Acta Microbiologica Hellenica, 24, 160–8.Google Scholar
Smeraldi, E., Bellodi, L. & Cazzullo, C. L. (1976) Further studies on the major histocompatibility complex as a genetic marker for schizophrenia. Biological Psychiatry, 11, 655–61.Google ScholarPubMed
Smeraldi, E., Scorza-Smeraldi, R., Bellodi, L., Fabio, L., Negri, F. & Bonara, P. (1978) The HLA system as a possible marker for psychiatric disorders. Paper presented at the 11th CINP Congress, Vienna.Google Scholar
Terasaki, P. & McClelland, J. D. (1964) Microdroplet assay of human serum cytotoxins. Nature, 204, 998–1000.Google Scholar
Turner, W. J. (1979) Genetic markers for schizotaxia. Biological Psychiatry, 14, 177–206.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.